Evidence map›Paper›PMID 41348365›Full record

ArticleChemistry & biodiversity2026

Core-Shell Photosensitizer-Fenton Heterostructure Boosts Tumor Inhibition for Synergistic Therapy.

Qingyue Yin, Liang Xu, Haiyang Li, Fukang Geng, Wenjing Zhao, Caihong Tao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qingyue YinSchool of Chemistry and Chemical Engineering, Lanzhou Jiaotong University, Lanzhou, People's Republic of China.
Liang XuSchool of Chemistry and Chemical Engineering, Lanzhou Jiaotong University, Lanzhou, People's Republic of China.
Haiyang LiSchool of Chemistry and Chemical Engineering, Lanzhou Jiaotong University, Lanzhou, People's Republic of China.
Fukang GengSchool of Chemistry and Chemical Engineering, Lanzhou Jiaotong University, Lanzhou, People's Republic of China.
Wenjing ZhaoSchool of Chemistry and Chemical Engineering, Lanzhou Jiaotong University, Lanzhou, People's Republic of China.
Caihong TaoSchool of Chemistry and Chemical Engineering, Lanzhou Jiaotong University, Lanzhou, People's Republic of China.ORCID https://orcid.org/0000-0003-1297-6265

Funding

Basic Research Top Talent Training Program of Lanzhou Jiaotong UniversityFoundation of a Hundred Youth Talents Training Program of Lanzhou Jiaotong University
6 · The paper itself

Abstract

In this paper, a novel photosensitizer@Fenton reagent core-shell heterostructure is fabricated via a multiple self-assembly process, which exhibits a significant inhibitory effect on 4T1 cells (inhibition rate of 86.79%). Natural glucose oxidase (Gox) modified hollow mesoporous nano-manganese dioxide (H-MnO

Indexed as

Antineoplastic AgentsHydrogen PeroxideIronPhotosensitizing AgentsAnimalsCell Line, TumorCell ProliferationCell SurvivalDose-Response Relationship, DrugDrug Screening Assays, AntitumorGlucose OxidaseHumansIndolesManganese CompoundsMiceOxides2-(2-(2-chloro-3-((1,3-dihydro-3,3-dimethyl-1-propyl-2H-indol-2-ylidene)ethylidene)-1-cyclohexen-1-yl)ethenyl)-3,3-dimethyl-1-propylindoliumAntineoplastic AgentsFenton's reagentGlucose OxidaseHydrogen PeroxideIndolesIronManganese Compoundsmanganese dioxideOxidesPhotosensitizing Agentsbio‐recycling reactorchemodynamic therapyFenton nanoplatformoxygen generationphotothermal therapy

Identifiers

PMID41348365
PMCPMC13420628

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.